Marks Group Wealth Management’s Amdocs DOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.72M Sell
53,899
-22,776
-30% -$1.4M 0.24% 110
2026
Q1
$5M Sell
76,675
-4,562
-6% -$334K 0.48% 83
2025
Q4
$6.54M Sell
81,237
-9,043
-10% -$727K 0.63% 59
2025
Q3
$7.41M Sell
90,280
-2,205
-2% -$191K 0.69% 69
2025
Q2
$8.44M Sell
92,485
-1,511
-2% -$135K 0.78% 56
2025
Q1
$8.6M Buy
93,996
+3,164
+3% +$276K 0.83% 46
2024
Q4
$7.73M Sell
90,832
-3,369
-4% -$296K 0.76% 58
2024
Q3
$8.24M Buy
94,201
+1,619
+2% +$136K 0.79% 62
2024
Q2
$7.31M Buy
92,582
+16,952
+22% +$1.39M 0.77% 61
2024
Q1
$6.83M Buy
75,630
+555
+0.7% +$50.6K 0.71% 65
2023
Q4
$6.6M Buy
75,075
+915
+1% +$76.2K 0.75% 60
2023
Q3
$6.27M Buy
74,160
+436
+0.6% +$39.4K 0.78% 53
2023
Q2
$7.29M Buy
73,724
+684
+0.9% +$64.4K 0.87% 40
2023
Q1
$7.01M Buy
73,040
+106
+0.1% +$9.81K 0.9% 32
2022
Q4
$6.63M Buy
72,934
+253
+0.3% +$21.5K 0.91% 29
2022
Q3
$5.78M Buy
72,681
+1,680
+2% +$142K 0.88% 38
2022
Q2
$5.92M Sell
71,001
-14,197
-17% -$1.17M 0.85% 31
2022
Q1
$7M Buy
85,198
+5,020
+6% +$393K 0.88% 29
2021
Q4
$5.99M Buy
80,178
+7,508
+10% +$564K 0.73% 54
2021
Q3
$5.51M Buy
72,670
+339
+0.5% +$26.2K 0.75% 54
2021
Q2
$5.59M Sell
72,331
-13
-0% -$1K 0.77% 52
2021
Q1
$5.07M Sell
72,344
-4,255
-6% -$321K 0.75% 60
2020
Q4
$5.43M Buy
76,599
+83
+0.1% +$5.21K 0.85% 35
2020
Q3
$4.39M Buy
76,516
+46,263
+153% +$2.77M 0.79% 56
2020
Q2
$1.83M Buy
+30,253
New +$1.87M 0.37% 105

Other funds holding DOX

Marks Group Wealth Management's DOX Position: Q2 2026 in Review

Marks Group Wealth Management reduced its Amdocs (DOX) stake by 30% in Q2 2026, selling an estimated $1.4M and leaving 53,899 shares worth $2.72M. The position accounts for 0.24% of the portfolio, ranked #110.

Marks Group Wealth Management first reported a position in DOX in Q2 2020 and has held it in 25 quarters since. The position peaked at $8.6M in Q1 2025. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.

  • Marks Group Wealth Management held 53,899 shares of Amdocs worth $2.72M as of Q2 2026.
  • Marks Group Wealth Management sold 22,776 Amdocs shares in Q2 2026, an estimated $1.4M.
  • Amdocs made up 0.24% of Marks Group Wealth Management's portfolio in Q2 2026, its #110 holding.
  • Marks Group Wealth Management first reported a position in Amdocs in Q2 2020 and has held it in 25 quarters since.
  • Marks Group Wealth Management's Amdocs position peaked at $8.6M in Q1 2025.
  • 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.

Based on Marks Group Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.